Leveraging the Benefits of Dietary Fibre for Cost Effective Treatment & Prevention in Type-2 Diabetes
Time: 11:00 am
day: Conference Day Two
Details:
- Discussing how Myota has leveraged the two main mechanisms of action, namely post-prandial glycaemic response regulation and Short Chain Fatty Acid production by the gut microbiome, to develop precision fibre blends aimed at treating and prevent Type-2 Diabetes
- Outlining the clinical trials currently underway for testing these blends in diabetic populations
